MetLife Investment Management, LLC
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in ACRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$164,512
+$87,466 QoQ
Shares Held
43,870
+71.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. ACRS ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in ACRS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $164,512 | 43,870 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $77,046 | 25,597 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $67,102 | 35,317 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $80,008 | 56,344 | Shares | Defined | 2025-08-13 | |
| 2023-09-30 | $240,846 | 35,160 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $364,609 | 35,160 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $274,242 | 33,899 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $533,909 | 33,899 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $492,205 | 31,271 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $436,543 | 31,271 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $453,101 | 26,282 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $241,102 | 16,582 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $298,476 | 16,582 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $291,179 | 16,582 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||